Showing results (1-10 of 32) with videos related to
Sort By:
Pageof 4
Wiley Interdisciplinary Reviews. RNA|August 3, 2025
Unraveling the Role of Topoisomerase 3β (TOP3B) in mRNA Translation and Human DiseaseJulia E Warrick, Michael G KearseBio-Protocol|March 12, 2026
Selective Isolation of TOP3B•mRNA Covalent Intermediates Using Denaturing Oligo-dT PulldownJulia E Warrick, Michael G KearseThe Journal of Biological Chemistry|November 3, 2022
A noncanonical RNA-binding domain of the fragile X protein, FMRP, elicits translational repression independent of mRNA G-quadruplexesMaKenzie R Scarpitti, Julia E Warrick, Evelyn L Yoder, et al.Journal of Virology|October 14, 2025
Single-base m6A epitranscriptomics reveals novel HIV-1 host interaction targets in primary CD4+ T cellsSiyu Huang, Yutao Zhao, Stacia Phillips, et al.Biorxiv : the Preprint Server for Biology|May 15, 2025
An autism spectrum disorder mutation in Topoisomerase 3β causes accumulation of covalent mRNA intermediates by disrupting metal binding within the zinc finger domainJulia E Warrick, Durga Attili, Trevor van Eeuwen, et al.Nucleic Acids Research|November 5, 2025
An autism spectrum disorder mutation in Topoisomerase 3β causes accumulation of covalent mRNA intermediates by disrupting metal binding within the zinc finger domainJulia E Warrick, Durga Attili, Trevor van Eeuwen, et al.Cell Chemical Biology|April 16, 2021
A double on the Rocs with a twist: Rocaglamide A targets multiple DEAD-box helicases to inhibit translation initiationDaisy J DiVita, Michael G KearseGenes & Development|October 7, 2017
Non-AUG translation: a new start for protein synthesis in eukaryotesMichael G Kearse, Jeremy E WiluszNeurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|July 10, 2014
Repeat-associated non-AUG translation and its impact in neurodegenerative diseaseMichael G Kearse, Peter K ToddBio-Protocol|August 28, 2023
In vitro Analysis of Stalled Ribosomes Using Puromycin IncorporationMaKenzie R Scarpitti, Michael G KearsePageof 4